IDMI Insider Trading Activity and SEC Form 4 Filings
IDMI insider trading summary
No open-market insider purchases or sales of Idm Pharma, Inc. (IDMI) have been reported on SEC Form 4 in the past 12 months.
Latest IDMI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 1, 2009 | Palo Alto Healthcare Master Fund, L.P. | 10% Owner | Sell | $96K (54,000 @ $1.77) |
| Aug 16, 2005 | Jean Deleage | Director | Buy | $0 (8,909 @ $0.00) |
| Aug 16, 2005 | Jean Deleage | Director | Buy | $0 (236,380 @ $0.00) |
| Aug 16, 2005 | Jean Deleage | Director | Buy | $0 (134,995 @ $0.00) |
| Aug 16, 2005 | Jean-Loup Romet-Lemonne | Chairman & CEO | Buy | $0 (324,867 @ $0.00) |
| Aug 16, 2005 | Donald L Drakeman | Director | Buy | $0 (2,624,279 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.